Asker Healthcare Q2 FY26 profit rises to SEK 225 million; net sales climb 18% to SEK 4.69 billion

• Asker Healthcare Group AB posted Q2 net sales of SEK 4.69 billion, up 18% year over year.
• EBIT rose 40.16% to SEK 349 million; profit for the quarter climbed 69.17% to SEK 225 million.
• Adjusted EBITA increased 24% to SEK 471 million; the adjusted EBITA margin widened 0.5 percentage points to 10%.
• Adjusted cash flow from operating activities improved to SEK 330 million from the prior year’s quarter.
• CEO Johan Falk cited steady growth outperforming the market, strong earnings leverage from scale, one acquisition signed, and good visibility on acquisition candidates.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Asker Healthcare Group AB published the original content used to generate this news brief via Cision (Ref. ID: 20260720:BIT:0421:0) on July 21, 2026, and is solely responsible for the information contained therein.